However, to the best of our knowledge, no fused Axl-targeting affibody with an EGFR targeting affibody to form dual-target affibody for the diagnosis and targeted therapy of NPC in nude mice model has been reported. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.